A small antibiotic called plectasin uses an innovative mechanism to kill bacteria. By assembling into large structures, plectasin latches onto its target on the bacterial cell surface comparable to how both sides of Velcro form a bond.
Mainz Biomed Partners with Liquid Biosciences to Harness the Power of Artificial Intelligence (AI) to Develop Next-generation Colorectal Screening Test – Biotech Investments
Issuer: Mainz BioMed N.V. / Key word(s): Miscellaneous 09.11.2023 / 14:01 CET/CEST The issuer is solely responsible for the content of this announcement. Mainz Biomed